Just before Christmas🎄, my weekly Biomeds News report is out. Growing evidence shows the clinical relevance of mutant p53 in treatment response, positioning it as a key axis in anticancer therapy. @biomednews.bsky.social #p53 #Oncology biomed.news/bims-p53act/... Merry Christmas!!!

🧬Mutant p53 & anticancer therapy - weekly update. A curated snapshot of recent studies on therapy response, resistance and tumour adaptation across cancers. biomed.news/bims-p53act/... @biomednews.bsky.social #p53 #Oncology #CancerResearch

🧬 Our latest @biomednews.bsky.social report on mutant #p53 and anticancer therapy is out. Across multiple #Cancer types, recent studies highlight how TP53 #mutations intersect with tumor plasticity, DNA repair pathways, immune context and treatment response. biomed.news/bims-p53act/... #Oncology

Our new Biomed News issue on Mutant p53 & Anticancer Therapy is live - 9 fresh papers this week, spanning mechanisms, resistance, and new therapeutic angles. Great selection for anyone following the p53 field!🔬 biomed.news/bims-p53act/... @biomednews.bsky.social #p53 #CancerResearch #Oncology

🧬 New #BiomedNews report out in Mutant #p53 and anti-cancer therapies. Two recent papers highlight how specific TP53 mutations drive tumor behavior and reveal new therapeutic vulnerabilities. biomed.news/bims-p53act/... @biomednews.bsky.social

Take a look at our new report from @tonimarber.bsky.social

I’m excited to launch my first @biomednews.bsky.social report: p53 mutations and anti-cancer therapy response 🧬 Starting small with 2 papers, more coming as ernad learns! 🚀 Exploring how mutant #p53 drives therapy adaptation. biomed.news/bims-p53act/... (And yes, my own recent paper’s included 👀)

Thrilled to share that the main paper from my PhD thesis is finally out!🧬 Our study shows how mutant p53 boosts mitochondrial biogenesis and cell migration under chemotherapy stress. www.sciencedirect.com/science/arti... @gmot16.bsky.social @uib.cat @iunics-uib.bsky.social @idisba.bsky.social

Torn del Dr. Toni Martínez @tonimarber.bsky.social per explicar la seva tesi doctoral realitzada al grup @gmot16.bsky.social

Avui acabam el curs acadèmic 2024-25, i volem compartir algunes de les fites més destacades del grup de recerca GMOT aquest any. Comencem!👇

Per altra banda, el Dr. Toni Martínez @tonimarber.bsky.social, sota la direcció dels Drs. J. Oliver i J. Sastre, va centrar-se en l’estudi d’una mutació freqüent de la proteïna p53 i com pot impactar en la progressió del càncer colorectal. Enhorabona i bona sort amb el que t’espera a partir d’ara!🎉🔬

📣 Save the date! 23/06, 10:00h, sala grados B, ed. Jovellanos, UIB. @tonimarber.bsky.social defiende su tesis doctoral "Implicaciones de la mutación p53-R273H en la respuesta al oxaliplatino, la función mitocondrial y la señalización inflamatoria en el cáncer colorrectal". Don't miss it!🧫

🔥 Tu cuerpo no es un bosque, pero puede arder por dentro. El cáncer es el fuego. ¿Y si te digo que la obesidad es el viento que lo aviva? Tu cuerpo no es una metáfora… ¡Pero este #HiloTesis sí que lo es! 🌲🔥 @crueuniversidades.bsky.social @filarramendi.bsky.social @culturacientifica.uib.cat

Nou article a #Docusalut: Oxidative Phosphorylation as a Predictive Biomarker of Oxaliplatin Response in Colorectal Cancer http://hdl.handle.net/20.500.13003/21486 @idisba.bsky.social  #PublicaSalutIB

Kicking off my profile with some exciting news! 🎉 Part of my PhD thesis is now published: "Oxidative Phosphorylation as a Predictive Biomarker of Oxaliplatin Response in Colorectal Cancer" 🔬 Big thanks to the amazing GMOT team🙌 www.mdpi.com/3012746